ArticleJournal of managed care & specialty pharmacy2020

Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications.

Elmor D Pineda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.